In conclusion, this study did not reveal any pathogenic germline mutations and no apparent genomic deletions in SAFB1 or SAFB2, and the hypothesis that the two genes would function as tumour suppressor genes could not be verified in this patient based material. This evidence concerns the gene SAFB2 and neoplasm.